Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorBaşıbüyük, Mustafa
dc.contributor.authorElboğa, Umut
dc.contributor.authorÇelen, Y. Zeki
dc.contributor.authorKalender, Ebuzer
dc.contributor.authorDemir, Hasan Deniz
dc.contributor.authorŞahin, Ertan
dc.contributor.authorÖzkaya, Mesut
dc.date.accessioned2022-05-11T14:40:54Z
dc.date.available2022-05-11T14:40:54Z
dc.date.issued2015
dc.identifier.issn1309-0720
dc.identifier.issn1309-2014
dc.identifier.urihttps://doi.org/10.4328/JCAM.3317
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8959
dc.description.abstractAim: Hyperthyroidism is a condition in which the thyroid gland produces and secretes excessive amounts of the thyroid hormones into circulation. It is one of the common endocrinologic disorders. There are three methods in treatment of hyperthyroidism. These are antithyroid medication, radioactive iodine-131 (RAI) therapy and surgery. In this study, we aimed to evaluate RAI treatment efficacy in patients with hyperthyroidism in the light of laboratory results and clinical pictures. Material and Method: Two hundred and seventy six patients with hyperthyroidism (average age: 50.9 years, age range: 1882 years) who received RAI treatment and then followed up for at least 6 months were included in the study. Patients' medical recordings were analysed retrospectively. Results: Seventy one patients were men (average age: 51.2 years, age range: 18-80 years), the rest were women (average age: 50.7 years, age range: 18-82 years). According to thyroid ultrasound or physical examination findings, 102 patients had diffuse thyroid hyperplasia, the other patients had nondiffuse hyperplasia (nodular or multinodular). RAI was given to the patients once or twice, or three times if necessary. In first RAI treatment, average 13.1 mCi, in second, average 16.6 mCi, in third, average 25 mCi RAI were given orally. Treatment was accepted as successful if the patients had become hypothyroid or euthyroid. Success rate of RAI treatment was 76%. The highest success rate was obtained in patients who have diffuse thyroid hyperplasia. Serious side-effects were not observed in our patients. Discussion: In treatment of hyperthyriodism with RAI in our clinic we observed approximately similar success rates with the reported results in the literature, and also side-effects of RAI treatment were low. We believe that RAI treatment should be first choice for treatment of hyperthyroidism in selected patients, because it is easy to perform and its side- effects are very low.en_US
dc.language.isoturen_US
dc.publisherDerman Medical Publen_US
dc.identifier.doi10.4328/JCAM.3317
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHyperthyroidlsmen_US
dc.subjectRadioiodine Treatmenten_US
dc.subjectGraves-Diseaseen_US
dc.subjectRadioiodine-131 Therapyen_US
dc.subjectRatesen_US
dc.titleThe Evaluation of Patients with Hyperthyroidism Treated with Radioactive Iodine-131en_US
dc.typearticleen_US
dc.relation.ispartofJournal of Clinical and Analytical Medicineen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nükleer Tıp Ana Bilim Dalıen_US
dc.authorid0000-0002-3650-8258
dc.authorid0000-0001-5364-1299
dc.identifier.volume6en_US
dc.identifier.startpage58en_US
dc.identifier.endpage61en_US
dc.institutionauthorKalender, Ebuzer
dc.institutionauthorŞahin, Ertan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorwosidSahin, Ertan/AAG-8999-2020
dc.authorwosidELBOGA, UMUT/AAH-1320-2020
dc.authorwosidÇelen, Yusuf Zeki/AAG-8083-2020
dc.identifier.wosWOS:000215585400028en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster